About this Research Topic
In this Research Topic, we may discuss the following in the setting of ECMO:
• Bleeding during ECMO: prevention and treatment
• The evolution of ECMO circuits over the past 20 years and impact on the incidence of thrombosis in the pediatric ECMO population
• Use of bivalirudin (or argatroban) as a primary anticoagulant for ECMO in pediatric patients.
• ECMO CPR (ECPR)
• Anticoagulation and antiplatelet management for VADs in pediatric patients.
• Thromboelastography in Pediatric ECMO and VAD
• ECMO in COVID (adult)
Topic Editor Jean Connors received financial support from CSL Behring. The other Topic Editors declare no conflict of interest in regard to this Research Topic.
Keywords: ECMO, VAD, coagulation, thrombosis, bleeding
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.